Innate Pharma(IPHA) - 2023 Q1 - Earnings Call Presentation

Q1 2023 Business Update 10 MAY 2023 Disclaimer on Forward-Looking Information and Risk Factors This document has been prepared by Innate Pharma S.A. (the “Company”) solely for the purposes of a presentation to investors concerning the Company. This document is not to be reproduced by any person, nor to be distributed. 2 Speakers on Today’s Call Mondher Mahjoubi Joyson Karakunnel Yannis Morel Frédéric Lombard MD MD, MSc, FACP PhD MBA (Q&A) Chief Medical Officer Head of Business Development Chief Financial Of ...